Immuneed AB

Immuneed is a Swedish CRO specializing in advanced ex vivo characterization of biopharmaceuticals to detect first-in-man immune reactions before clinical trials. Its core technology ID.Flow® keeps fresh human blood circulating at 37°C, simulating human blood circulation. Offers cytokine release, immune cell activation, and complement activation analyses. Headquartered in Uppsala, founded 2014. Ultimovacs acquired part of its business in 2018.